Join to View Full Profile
800 NE 10th StSte 5050Oklahoma City, OK 73104
Phone+1 405-271-8001
Fax+1 919-966-2646
Dr. Dockery is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Tufts Medical CenterResidency, Obstetrics and Gynecology, 2012 - 2016
Virginia Commonwealth University School of MedicineClass of 2012
Certifications & Licensure
OK State Medical License 2015 - 2025
NC State Medical License 2019 - 2023
MA State Medical License 2012 - 2016
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
- Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer Start of enrollment: 2020 Jun 29
Roles: Contact
Publications & Presentations
PubMed
- First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer.Nehal J Lakhani, Daphne Stewart, Debra L Richardson, Lauren E Dockery, Linda Van Le
Journal for Immunotherapy of Cancer. 2025-01-11 - 1 citationsEffectiveness of PARP Inhibitor Maintenance Therapy in Ovarian Cancer by BRCA1/2 and a Scar-Based HRD Signature in Real-World Practice.Debra L Richardson, Julia C F Quintanilha, Natalie Danziger, Gerald Li, Ethan Sokol
Clinical Cancer Research. 2024-10-15 - 1 citationsDeveloping a Novel Image Marker to Predict the Clinical Outcome of Neoadjuvant Chemotherapy (NACT) for Ovarian Cancer Patients.Ke Zhang, Neman Abdoli, Patrik Gilley, Youkabed Sadri, Xuxin Chen
Arxiv. 2024-07-03
Press Mentions
Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with Nab-Sirolimus at Society of Gynecologic Oncology (SGO)March 18th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
